Cargando…

Systemic inflammation and residual viraemia in HIV-positive adults on protease inhibitor monotherapy: a cross-sectional study

BACKGROUND: Increased levels of markers of systemic inflammation have been associated with serious non-AIDS events even in patients on fully suppressive antiretroviral therapy. We explored residual viremia and systemic inflammation markers in patients effectively treated with ritonavir-boosted prote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arenas-Pinto, Alejandro, Milinkovic, Ana, Peppa, Dimitra, McKendry, Anna, Maini, Mala, Gilson, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374398/ https://www.ncbi.nlm.nih.gov/pubmed/25888119 http://dx.doi.org/10.1186/s12879-015-0889-9

Ejemplares similares

Next generation sequencing of HIV-1 protease in the PIVOT trial of protease inhibitor monotherapy
por: Dunn, David T., et al.
Publicado: (2018)

NK Cells: A Double-Edged Sword in Chronic Hepatitis B Virus Infection
por: Maini, Mala K., et al.
Publicado: (2013)

Control of HIV viraemia is not enough in perinatal HIV
por: Foster, Caroline, et al.
Publicado: (2015)

Risky Alcohol Consumption and Associated Health Behaviour Among HIV-Positive and HIV-Negative Patients in a UK Sexual Health and HIV Clinic: A Cross-Sectional Questionnaire Study
por: Suonpera, Emmi, et al.
Publicado: (2019)

Adaptive Reconfiguration of Natural Killer Cells in HIV-1 Infection
por: Peppa, Dimitra, et al.
Publicado: (2018)

Cardiovascular markers of inflammation and serum lipid levels in HIV-infected patients with undetectable viraemia
por: Viskovic, Klaudija, et al.
Publicado: (2014)

Plasma viraemia in HIV-positive pregnant women entering antenatal care in South Africa
por: Myer, Landon, et al.
Publicado: (2015)

HIV: how to manage low-level viraemia in people living with HIV
por: Hanners, Emily K, et al.
Publicado: (2022)

Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia
por: Nightingale, Sam, et al.
Publicado: (2016)

Low clinical relevance of risky alcohol consumption in a selected group of high adherent HIV-infected patients attended in the United Kingdom
por: Gonzalez Baeza, Alicia, et al.
Publicado: (2014)

Low-level viraemia during treatment with darunavir/r monotherapy versus DRV/r + 2NRTIs in the MONET trial
por: Clumeck, N, et al.
Publicado: (2010)

HIV-2 gene product-specific T cell responses and viraemia control
por: Leligdowicz, Aleksandra, et al.
Publicado: (2006)

Low level viraemia and the risk of virological failure in HIV infected patients
por: Florea, Dragoş, et al.
Publicado: (2014)

Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial
por: Paton, Nicholas I, et al.
Publicado: (2015)

Plasma IP-10 Concentrations Correlate Positively with Viraemia and Inversely with CD4 Counts in Untreated HIV Infection
por: Mhandire, Kudakwashe, et al.
Publicado: (2017)

The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review
por: Broyles, Laura N, et al.
Publicado: (2023)

Mobility during the post-partum period and viraemia in women living with HIV in South Africa
por: Odayar, Jasantha, et al.
Publicado: (2023)

JC viraemia in kidney transplant recipients: to act or not to act?
por: Rao, N., et al.
Publicado: (2012)

Steroid harms if given early in COVID-19 viraemia
por: Arora, Kanupriya, et al.
Publicado: (2021)

Blockade of Immunosuppressive Cytokines Restores NK Cell Antiviral Function in Chronic Hepatitis B Virus Infection
por: Peppa, Dimitra, et al.
Publicado: (2010)

Upregulation of the Tim-3/Galectin-9 Pathway of T Cell Exhaustion in Chronic Hepatitis B Virus Infection
por: Nebbia, Gaia, et al.
Publicado: (2012)

Entering a new era of harnessing natural killer cell responses in HIV infection
por: Peppa, Dimitra
Publicado: (2019)

Patterns of detectable viraemia among children and adults with HIV infection taking antiretroviral therapy in Zimbabwe
por: Sovershaeva, Evgeniya, et al.
Publicado: (2019)

CD8 encephalitis with CSF EBV viraemia and HIV drug resistance, a case series
por: Kerr, C., et al.
Publicado: (2020)

Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study
por: Estébanez, Miriam, et al.
Publicado: (2014)

Interferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo
por: Gill, Upkar S., et al.
Publicado: (2016)

Pleural effusion disease in rabbits: Observations on viraemia, immunity and transmissibility
por: Fennestad, K. L., et al.
Publicado: (1981)

Low-level viraemia despite emergence of dolutegravir-resistant variants
por: Botha, Johannes C., et al.
Publicado: (2022)

Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study
por: Leierer, Gisela, et al.
Publicado: (2015)

Cytomegalovirus viraemia is associated with poor growth and T-cell activation with an increased burden in HIV-exposed uninfected infants
por: Garcia-Knight, Miguel A., et al.
Publicado: (2017)

Low-level viraemia among people living with HIV in Nigeria: a retrospective longitudinal cohort study
por: Chun, Helen M, et al.
Publicado: (2022)

Perioperative Intravenous Fluid Therapy for Adults
por: Sweeney, Rob Mac, et al.
Publicado: (2013)

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
por: Ndieyira, Joseph W., et al.
Publicado: (2013)

Exploring People’s Candidacy for Mobile Health–Supported HIV Testing and Care Services in Rural KwaZulu-Natal, South Africa: Qualitative Study
por: Adeagbo, Oluwafemi, et al.
Publicado: (2019)

HIV-1 subtype influences susceptibility and response to monotherapy with the protease inhibitor lopinavir/ritonavir
por: Sutherland, K. A., et al.
Publicado: (2015)

Difference in factors associated with low-level viraemia and virological failure: results from the Austrian HIV Cohort Study
por: Leierer, Gisela, et al.
Publicado: (2014)

HIV viraemia during pregnancy in women receiving preconception antiretroviral therapy in KwaDukuza, KwaZulu-Natal
por: Ntlantsana, Vuyokazi, et al.
Publicado: (2019)

Factors associated with low-level viraemia in people with HIV starting antiretroviral therapy: A Swedish observational study
por: Brattgård, Hanna, et al.
Publicado: (2022)

Low-level viraemia: An emerging concern among people living with HIV in Uganda and across sub-Saharan Africa
por: Nanyeenya, Nicholus, et al.
Publicado: (2022)

Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammation
por: Torres, Berta, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_342je1rjamdkh2t35qtd0s8ecs